Cetera Investment Advisers
ROIV icon

Cetera Investment Advisers’s Roivant Sciences ROIV Stock Holding History

Cetera Investment Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16M Buy
174,115
+4,670
+3% +$138K 0.01% 1461
2026
Q1 		$4.69M Buy
169,445
+12,873
+8% +$331K 0.01% 1543
2025
Q4 		$3.4M Buy
156,572
+140,620
+882% +$2.77M ﹤0.01% 1755
2025
Q3 		$241K Buy
+15,952
New +$197K ﹤0.01% 4014
2024
Q3 		– Sell
-100,288
Closed -$1.06M – 3882
2024
Q2 		$1.06M Buy
100,288
+28,324
+39% +$310K ﹤0.01% 2031
2024
Q1 		$759K Buy
+71,964
New +$776K ﹤0.01% 2291

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cetera Investment Advisers's ROIV Position: Q2 2026 in Review

Cetera Investment Advisers increased its Roivant Sciences (ROIV) stake by 2.8% in Q2 2026, buying an estimated $138K and bringing the position to 174,115 shares worth $6.16M. The position accounts for 0.01% of the portfolio, ranked #1461.

Cetera Investment Advisers first reported a position in ROIV in Q1 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Cetera Investment Advisers held 174,115 shares of Roivant Sciences worth $6.16M as of Q2 2026.
  • Cetera Investment Advisers bought 4,670 Roivant Sciences shares in Q2 2026, an estimated $138K.
  • Roivant Sciences made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1461 holding.
  • Cetera Investment Advisers first reported a position in Roivant Sciences in Q1 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.